Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Radiation Oncology Physician in Paoli, PA
NPI: 1467496877Primary Employer
Centers for Advanced Urology, LLP
midlanticurology.com
HQ Phone
Get M.D. Stephen's Phone Numberphone_androidMobile
Get M.D. Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
PA State Medical License
1985 - 2024
NJ State Medical License
2004 - 2023
DE State Medical License
2009 - 2013
American Board of Internal Medicine
Internal Medicine
American Board of Radiology
Radiation Oncology
University of Pennsylvania Health System
Residency • Radiation Oncology
1986 - 1989
Residency • Internal Medicine
1983 - 1986
New York University School of Medicine
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 81 | 1,581 |
| 2 | 77427Radiation treatment management, 5 treatment sessions | 75 | 306 |
| 3 | 77336Radiation therapy consultation per week | 72 | 285 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 71 | 72 |
| 5 | 77014Ct scan guidance for insertion of radiation therapy fields | 61 | 926 |
Authors: Rachelle Lanciano, Anthony Ricco, Olusola Obayomi-Davies
Journal: Adv Radiat Oncol
Publication Date: 2020-06-25
Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience
Authors: William Ding
Publication Date: 2015-05
SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines.
Authors: Jun Yang, Caspian Oliai, Bruce Garber
Publication Date: 2014-09-01